DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
McDermott DF, Huseni MA, Atkins MB. et al.
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Nature medicine 2018;
24: 749-757
DOI: 10.1038/s41591-018-0053-3.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.